Novel Therapies to Address Unmet Needs in ITP

Primary immune thrombocytopenia (ITP) is an autoimmune disorder that causes low platelet counts and subsequent bleeding risk. Although current corticosteroid-based ITP therapies are able to improve platelet counts, up to 70% of subjects with an ITP diagnosis do not achieve a sustained clinical respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mingot-Castellano, María Eva, Bastida, José María, Caballero-Navarro, Gonzalo, Entrena Ureña, Laura, González-López, Tomás José, González-Porras, José Ramón, Butta, Nora, Canaro, Mariana, Jiménez-Bárcenas, Reyes, Gómez del Castillo Solano, María del Carmen, Sánchez-González, Blanca, Pascual-Izquierdo, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318546/
https://www.ncbi.nlm.nih.gov/pubmed/35890078
http://dx.doi.org/10.3390/ph15070779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318546/
https://www.ncbi.nlm.nih.gov/pubmed/35890078
http://dx.doi.org/10.3390/ph15070779

Ejemplares similares